Press "Enter" to skip to content

Top stocks in focus: Aurobindo Pharma, Reliance Industries, Cadila, Britannia, 3i Infotech – Indiainfoline

Aurobindo Pharma reported lower profit at Rs696.7cr in Q2FY22 against Rs807.2cr in Q2FY21; revenue declined to Rs5,941.9cr from Rs6,483.4cr yoy.

Reliance Industries: Step-down subsidiary Reliance Eagleford Upstream Holding, LP signed agreements with Ensign Operating III, LLC, a Delaware-based limited liability company, to divest its interest in certain upstream assets in the Eagleford shale play of Texas, USA. With this transaction, Reliance has divested all its shale gas assets and has exited from the shale gas business in North America.

Cadila Healthcare received an order to supply 1 crore doses of ZyCoV-D vaccine to the government at Rs265 per dose.

Britannia Industries reported lower profit at Rs381.8cr in Q2FY22 against Rs495.2cr in Q2FY21; revenue increased to Rs3,607.4cr from Rs3,419.1cr yoy.

3i Infotech reported loss of Rs23.1cr in Q2FY22 against loss of Rs12.9cr in Q2FY21; revenue increased to Rs177.1cr from Rs152.1cr yoy.

EID Parry (India) reported lower consolidated profit at Rs470.35cr in Q2FY22 against Rs562.70cr in Q2FY21. Revenue jumped to Rs6,978.41cr from Rs5,836.21cr yoy.

Results today: Bosch, Mahindra & Mahindra, Power Grid Corporation, Astrazeneca Pharma, BHEL, HEG, Indraprastha Gas, MRF and Petronet LNG among 160 companies.